Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients
Multi-Center, Double-Blind Study to Compare the Effects of 30mg Qd Versus 15 Mg Bid of Tolvaptan in Congestive Heart Failure Patients
1 other identifier
interventional
40
1 country
9
Brief Summary
Patients with congestive heart failure will be assessed for safety and clinical effects of Tolvaptan 30 mg every day versus 15 mg twice a day over a period of 7 days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started May 2002
Shorter than P25 for phase_2
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2002
CompletedFirst Submitted
Initial submission to the registry
August 13, 2002
CompletedFirst Posted
Study publicly available on registry
August 14, 2002
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2002
CompletedJune 24, 2005
September 1, 2002
August 13, 2002
June 23, 2005
Conditions
Keywords
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (9)
Central Cardiology Medical Clinic
Bakersfield, California, United States
University of California-San Diego
San Diego, California, United States
University of Miami/Jackson Memorial Hospital
Miami, Florida, United States
Medical Research Institute
Slidell, Louisiana, United States
Androscoggin Cardiology Associates
Auburn, Maine, United States
University of Missouri-Kansas City School of Medicine
Kansas City, Missouri, United States
Saint Louis University
St Louis, Missouri, United States
Cardiology of Oklahoma
Tulsa, Oklahoma, United States
Medical University of South Carolina
Charleston, South Carolina, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
August 13, 2002
First Posted
August 14, 2002
Study Start
May 1, 2002
Study Completion
September 1, 2002
Last Updated
June 24, 2005
Record last verified: 2002-09